Bryan Johnson's Blueprint: What It Gets Right, What the Evidence Shows, and What to Actually Take From It
Bryan Johnson is a tech entrepreneur who, according to a 2023 Bloomberg profile, spends about $2 million a year on a heavily monitored protocol meant to slow or reverse his biological age. His Blueprint project is part self-experiment and part business. Here is what it gets right, what remains unproven, and what applies to everyone else.
- Blueprint is a self-tracking project: Bryan Johnson follows a fixed diet, supplement, exercise and sleep routine, measures a large panel of biomarkers, and has tried a series of experimental procedures.
- The elements with the strongest supporting evidence are consistent sleep, a vegetable-rich diet low in ultra-processed food, regular aerobic exercise, resistance training and routine biomarker monitoring.
- The experimental elements, from high-dose NMN to young-plasma exchange, lack trial evidence of benefit in humans. Johnson himself has dropped some of them: young-plasma exchange in 2023 and rapamycin in 2024.
- Johnson reports improvements in biological age measures, including DunedinPACE, on his own site. These are self-reported, single-person results without a control group, so no specific intervention can be credited.
- The parts anyone can copy are also the best supported: consistent sleep, a mostly whole-food diet and regular exercise. They cost little.
Bryan Johnson has become one of the most publicly discussed figures in longevity science - not because he is a scientist or physician, but because he has committed an extraordinary amount of money and personal discipline to testing whether the current state of longevity science, applied maximally and rigorously, can meaningfully slow or reverse biological aging in a living human being. His Blueprint project is a genuine contribution to the field as a proof-of-concept experiment. It is also, necessarily, a single-subject uncontrolled self-experiment with significant confounding from media attention, financial incentives to report positive results, and the impossibility of separating the effects of any individual intervention from the overall protocol.1
What Blueprint Actually Consists Of
As described on his Blueprint site,1 the protocol has included a fixed early bedtime, a mostly plant-based diet built around vegetables, legumes, nuts and olive oil, dozens of supplements, daily aerobic and resistance exercise, frequent blood tests, imaging and epigenetic age testing, and periodic experimental procedures. It changes over time. In 2023 he stopped young-plasma exchange after six one-liter exchanges, saying it did not add benefit in his case.2 In late 2024 he stopped rapamycin after nearly five years, citing skin and soft tissue infections, abnormal blood lipids, raised glucose and a higher resting heart rate.6
A 2023 Bloomberg profile put the cost at about $2 million a year (as reported by Fortune). Few people outside research studies are monitored this closely.
What Blueprint Gets Right
The foundation of Blueprint - sleep consistency, high vegetable diet, elimination of ultra-processed food, daily exercise, comprehensive biomarker tracking - is exactly what the evidence-based longevity literature recommends. These elements are not controversial. Higher cardiorespiratory fitness, for example, is strongly linked to lower long-term mortality.3 If Johnson's reported improvements are real, these are the components with the strongest evidence behind them.
The monitoring philosophy is also genuinely valuable: regular, comprehensive biomarker measurement provides feedback loops that most people lack. Tracking fasting insulin, ApoB, Lp(a), hsCRP, epigenetic age, grip strength, VO2 max, and bone density over time makes it possible to identify adverse trends and intervene before clinical disease develops. This approach to health as a measurable and optimizable system is a genuinely important conceptual contribution, even if the specific interventions Johnson uses remain experimental.
The Experimental Elements: What the Evidence Shows
High-dose NMN: as covered in our NMN vs NR article, human trials show that NMN raises NAD+ levels and some show modest metabolic effects, but there are no long-term outcome data. Rapamycin: in mice it extended lifespan even when started late in life.4 No human trial has shown that it extends life, and Johnson stopped taking it in 2024 because of side effects.6 Young-plasma exchange: based on mouse studies in which young blood appeared to rejuvenate old tissue. In 2019 the FDA warned that infusions of plasma from young donors have no proven benefit for age-related conditions, and Johnson discontinued the exchanges after reporting no added benefit.2 Spermidine: it promotes autophagy in laboratory studies and is linked to longevity in observational data, but in a 12-month randomized trial of 100 older adults with subjective cognitive decline, spermidine supplements did not improve memory or biomarkers compared with placebo.7
The n=1 Problem
Blueprint is a rigorous self-experiment by longevity standards - comprehensive monitoring, consistent protocol, self-published data. But it is fundamentally a single-subject experiment, and the limitations of n=1 experiments are not resolved by the sophistication of the monitoring. Johnson's biological age improvements could be caused by any single element of his protocol, by the combination, by regression to the mean, by the psychophysiological effects of being the focus of intense personal attention and social support, or by factors completely unrelated to his interventions. There is no control condition, no randomization, and no ability to blind. The data is real and interesting. The causal conclusions that the popular media draws from it are not justified.5
What Is Actually Applicable at Any Budget
| Blueprint Element | What the evidence shows | Cost to copy | Verdict |
|---|---|---|---|
| Consistent, sufficient sleep | Supported, mostly by observational studies | Free | Do this first |
| Vegetable-rich diet, little ultra-processed food | Supported by trials and cohort studies | Low to moderate | Do this first |
| Regular aerobic and resistance exercise | Strong: higher fitness is linked to much lower mortality3 | Low | Do this first |
| Routine bloodwork (lipids including ApoB, glucose, blood pressure checks) | Useful for finding treatable risk factors | Varies; often covered by insurance | Follow your clinician’s schedule |
| High-dose NMN/NR | Raises blood NAD+; no long-term outcome data | Moderate, ongoing | Optional, experimental |
| Intermittent rapamycin | Extends life in mice4; small human trials show short-term safety, not slower aging | Prescription only | Experimental; only with a physician |
| Young-plasma exchange | No proven benefit; FDA warning (2019)2 | High | Not recommended outside trials |
Put this research into practice: Protocol Comparison Tool · Protocol Cost Calculator
References
- 1Johnson B. "Blueprint." blueprint.bryanjohnson.co. Accessed 2025.
- 2Fortune. Report on Bryan Johnson ending young-plasma exchange, quoting the FDA's 2019 statement on young-donor plasma. July 8, 2023. Link
- 3Mandsager K, et al. "Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing." JAMA Netw Open. 2018;1(6):e183605. PubMed · DOI
- 4Harrison DE, et al. "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice." Nature. 2009;460(7253):392-5. PubMed · DOI
- 5Smith GD, Ebrahim S. "'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?" Int J Epidemiol. 2003;32(1):1-22. PubMed · DOI
- 6Men's Fitness. Bryan Johnson stopped taking anti-aging drug rapamycin due to negative side effects. November 2024. Link
- 7Schwarz C, et al. "Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial." JAMA Netw Open. 2022;5(5):e2213875. PubMed · DOI
